Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
SEngine Precision Medicine
company
About
SEngine Precision Medicine has engineered an innovative approach to identify and develop the next generation of cancer targeted drugs.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3.10M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
SEngine Precision Medicine has engineered an innovative approach to identify and develop the next generation of cancer targeted drugs. Built on its Founders’ work of more than 25 years at the Fred Hutchinson Cancer Research Center, SEngine employs functional genomics and robotic testing of drugs in live patient organoids to match newly developed drugs to individual cancer patients. SEngine strives to fulfill the promise of personalized medicine providing cancer patients with effective, targeted, and less-toxic treatments.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$21.20M
SEngine Precision Medicine has raised a total of
$21.20M
in funding over 2 rounds. Their latest funding was raised on
Jul 28, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 28, 2022 | Series A | $10M | 1 | — | — | Detail |
| Oct 2, 2019 | Series A | $5.10M | 1 |
|
— | Detail |
| Oct 29, 2018 | Series Unknown | $3M | 1 |
|
— | Detail |
| May 2, 2018 | Grant | $3.10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
SEngine Precision Medicine is funded by 2 investors.
Bangarang Group
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
